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Background: Medtronic Sprint Fidelis leads have an estimated failure rate of 2.3% per year. We report the experience with Fidelis lead extraction 
at an academic center with a large electrophysiology program.
Methods: All lead extractions at a large academic center between January 2003 and June 2009 were reviewed. Fidelis lead extractions (model 
#6948, #6949, #6930 and #6931) were studied. The age of the leads, indication for extraction, extraction technique, success/failure rates and 
adverse event rates were all analyzed.
Results: Three hundred and sixty three leads were removed from 295 patients. There were 89 Fidelis leads (24.5%) in 88 patients (29.8%) which 
included 88 #6949 leads and 1 #6931 lead. Approximately 25% of leads had fractured. 75% were prophylactically removed, mostly at the time 
of a clinically indicated generator change. All leads were extracted by 5 electrophysiologists. Mean duration of lead implant was 23.8 +/- 12.8 
months. All of the leads except one was active fixation. Sixty-eight percent were at the RV apex and the remainder were at various RV septal sites. 
All leads were extracted by a superior approach. Fifty one percent were extracted by simple traction. Twenty one percent required a locking stylette. 
Electrodissection was used for two leads, and Evolution(™) was used for 13%. Mechanical sheath sets were used in 2% and laser in 10%. All 
leads were successfully removed. Six patients developed a small pocket hematoma (in the setting of pocket decortication). There were no other 
complications.
Conclusions: One hundred percent of Fidelis leads which were in for relatively brief periods of time were successfully removed with only minor 
adverse events noted.
